Gary B. Evans

4.3k total citations
104 papers, 3.4k citations indexed

About

Gary B. Evans is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Gary B. Evans has authored 104 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 26 papers in Epidemiology and 26 papers in Physiology. Recurrent topics in Gary B. Evans's work include Biochemical and Molecular Research (65 papers), Adenosine and Purinergic Signaling (26 papers) and HIV/AIDS drug development and treatment (22 papers). Gary B. Evans is often cited by papers focused on Biochemical and Molecular Research (65 papers), Adenosine and Purinergic Signaling (26 papers) and HIV/AIDS drug development and treatment (22 papers). Gary B. Evans collaborates with scholars based in United States, New Zealand and United Kingdom. Gary B. Evans's co-authors include Vern L. Schramm, Peter C. Tyler, Richard H. Furneaux, Andrzej Lewandowicz, Keith Clinch, Steven C. Almo, Vipender Singh, Kami Kim, Wuxian Shi and Gregory Kicska and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Gary B. Evans

103 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary B. Evans United States	37	2.5k	765	747	671	573	104	3.4k
Peter C. Tyler United States	45	4.1k 1.6×	1.6k 2.1×	1.3k 1.7×	1.2k 1.8×	908 1.6×	166	5.3k
Arthur Van Aerschot Belgium	39	4.2k 1.7×	1.5k 2.0×	1.2k 1.6×	549 0.8×	174 0.3×	314	5.6k
Luiz Augusto Basso Brazil	37	2.7k 1.1×	667 0.9×	1.5k 2.0×	942 1.4×	257 0.4×	221	4.2k
Diógenes Santiago Santos Brazil	36	2.8k 1.1×	449 0.6×	1.3k 1.7×	807 1.2×	286 0.5×	191	4.4k
Terry L. Bowlin United States	38	1.9k 0.8×	683 0.9×	843 1.1×	1.1k 1.6×	149 0.3×	161	4.6k
Ramandeep Singh India	29	1.3k 0.5×	503 0.7×	1.5k 2.0×	937 1.4×	86 0.2×	111	2.9k
Franck Amblard United States	22	1.2k 0.5×	1.4k 1.8×	878 1.2×	524 0.8×	94 0.2×	87	3.0k
Jan Balzarini Belgium	46	3.8k 1.5×	2.7k 3.5×	2.2k 2.9×	1.4k 2.1×	194 0.3×	213	7.6k
María‐Jesús Pérez‐Pérez Spain	34	1.7k 0.7×	1.5k 1.9×	1.6k 2.1×	428 0.6×	130 0.2×	150	3.7k
Ivan Votruba Czechia	32	1.9k 0.7×	1.5k 1.9×	1.4k 1.9×	955 1.4×	279 0.5×	186	3.8k

Countries citing papers authored by Gary B. Evans

Since Specialization

Citations

This map shows the geographic impact of Gary B. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary B. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary B. Evans more than expected).

Fields of papers citing papers by Gary B. Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary B. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary B. Evans. The network helps show where Gary B. Evans may publish in the future.

Co-authorship network of co-authors of Gary B. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Gary B. Evans. A scholar is included among the top collaborators of Gary B. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary B. Evans. Gary B. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rustam, Yepy H., Michael S. Jackson, Vern L. Schramm, et al.. (2023). Phosphoinositide and redox dysregulation by the anticancer methylthioadenosine phosphorylase transition state inhibitor. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1868(9). 159346–159346.

Hsu, Jack Chun-Chieh, Maudry Laurent-Rolle, Joanna B. Pawlak, et al.. (2022). Viperin triggers ribosome collision-dependent translation inhibition to restrict viral replication. Molecular Cell. 82(9). 1631–1642.e6. 26 indexed citations

Li, Jun, Isha Mutreja, Gary J. Hooper, et al.. (2020). Combined Infection Control and Enhanced Osteogenic Differentiation Capacity on Additive Manufactured Ti‐6Al‐4V are Mediated via Titania Nanotube Delivery of Novel Biofilm Inhibitors. Advanced Materials Interfaces. 7(7). 26 indexed citations

Williams, Elsie M., Mark J. Calcott, Janine N. Copp, et al.. (2020). Intracellular complexities of acquiring a new enzymatic function revealed by mass-randomisation of active-site residues. eLife. 9. 9 indexed citations

Evans, Gary B., Vern L. Schramm, & Peter C. Tyler. (2015). The Immucillins: Design, Synthesis and Application of Transition- State Analogues. Current Medicinal Chemistry. 22(34). 3897–3909. 17 indexed citations

Valappil, Sabeel P., Humphrey H. P. Yiu, Laurent Bouffier, et al.. (2012). Effect of novel antibacterial gallium-carboxymethyl cellulose on Pseudomonas aeruginosa. Dalton Transactions. 42(5). 1778–1786. 24 indexed citations

Evans, Gary B. & Graeme J. Gainsford. (2011). (4aR,6aS,10aR,10bS)-7,7,10a-Trimethyl-1,4,4a,5,6,6a,7,8,9,10,10a,10b-dodecahydro-2H-naphtho[2,1-c]pyran (Pyamber). Acta Crystallographica Section E Structure Reports Online. 67(11). o2870–o2870. 1 indexed citations

Cassera, María B., Keith Z. Hazleton, Emilio Merino, et al.. (2011). Plasmodium falciparum Parasites Are Killed by a Transition State Analogue of Purine Nucleoside Phosphorylase in a Primate Animal Model. PLoS ONE. 6(11). e26916–e26916. 55 indexed citations

Ho, Meng-Chiao, Wuxian Shi, Agnes Rinaldo-Matthis, et al.. (2010). Four generations of transition-state analogues for human purine nucleoside phosphorylase. Proceedings of the National Academy of Sciences. 107(11). 4805–4812. 68 indexed citations

10.

Rinaldo-Matthis, Agnes, Andrew S. Murkin, U.A. Ramagopal, et al.. (2007). l -Enantiomers of Transition State Analogue Inhibitors Bound to Human Purine Nucleoside Phosphorylase. Journal of the American Chemical Society. 130(3). 842–844. 19 indexed citations

11.

Lewandowicz, Andrzej, Erika A. Taylor, Li-Min Ting, et al.. (2005). Energetic Mapping of Transition State Analogue Interactions with Human and Plasmodium falciparum Purine Nucleoside Phosphorylases. Journal of Biological Chemistry. 280(34). 30320–30328. 45 indexed citations

12.

Ting, Li-Min, Wuxian Shi, Andrzej Lewandowicz, et al.. (2004). Targeting a Novel Plasmodium falciparum Purine Recycling Pathway with Specific Immucillins. Journal of Biological Chemistry. 280(10). 9547–9554. 91 indexed citations

13.

Shi, Wuxian, Li-Min Ting, Gregory Kicska, et al.. (2004). Plasmodium falciparum Purine Nucleoside Phosphorylase. Journal of Biological Chemistry. 279(18). 18103–18106. 94 indexed citations

14.

Evans, Gary B.. (2004). The Synthesis of N-Ribosyl Transferase Inhibitors Based on a Transition State Blueprint. Australian Journal of Chemistry. 57(9). 837–854. 4 indexed citations

15.

Evans, Gary B., et al.. (2004). Latent antithrombin and its detection, formation and turnover in the circulation. Journal of Thrombosis and Haemostasis. 2(12). 2170–2177. 42 indexed citations

16.

Kicska, Gregory, Peter C. Tyler, Gary B. Evans, et al.. (2002). Purine-less Death in Plasmodium falciparumInduced by Immucillin-H, a Transition State Analogue of Purine Nucleoside Phosphorylase. Journal of Biological Chemistry. 277(5). 3226–3231. 89 indexed citations

17.

Clinch, Keith, Gary B. Evans, Richard H. Furneaux, et al.. (2002). Synthesis and utility of sulfated chromogenic carbohydrate model substrates for measuring activities of mucin-desulfating enzymes. Carbohydrate Research. 337(12). 1095–1111. 18 indexed citations

18.

Evans, Gary B. & Richard H. Furneaux. (2000). The synthesis and antibacterial activity of totarol derivatives. part 2: modifications at C-12 and O-13. Bioorganic & Medicinal Chemistry. 8(7). 1653–1662. 13 indexed citations

19.

Evans, Gary B., Richard H. Furneaux, Graeme J. Gainsford, & Michael P. Murphy. (2000). The synthesis and antibacterial activity of totarol derivatives. part 3: modification of ring-B. Bioorganic & Medicinal Chemistry. 8(7). 1663–1675. 16 indexed citations

20.

Evans, Gary B., et al.. (1999). Potentiation of methicillin activity against methicillin-resistantStaphylococcus aureusby diterpenes. FEMS Microbiology Letters. 179(2). 233–239. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact